低强度激光治疗用于慢性创伤性脑损伤患者的随机对照试验研究方案
本研究为随机双盲试验方案,计划纳入36例中重度创伤性脑损伤患者,比较18次主动低强度激光治疗(LLLT)与假LLLT对抑制性注意控制的影响,并探索性评估情节记忆、执行功能及焦虑抑郁症状,评估在治疗前一周、治疗后一周及治疗后三个月进行。
要点
- 随机双盲试验,纳入36例中重度TBI患者,比较主动LLLT与假LLLT。
- 主动LLLT使用632 nm LED,颅区400 cm2照射30分钟,每次总剂量3.74 J/cm2,每周3次共6周18次。
- 主要评估抑制性注意控制,探索性评估记忆、执行功能及焦虑抑郁症状。
核心结论
- 该试验方案旨在评估18次主动LLLT对慢性TBI患者抑制性注意控制的疗效,并探索其对记忆、执行功能和情绪症状的作用。
研究设计与样本
- 随机双盲试验,计划纳入36例中度和重度TBI患者,比较主动LLLT与假LLLT。
- 主动LLLT使用LED设备发射632 nm辐射,全功率830 mW,照射颅区400 cm2共30分钟,每次总剂量3.74 J/cm2。
- 假LLLT组仅使用功率<1 mW的LED设备模拟照射。
- 每组患者每周照射3次,持续6周,共18次。
- 神经心理评估在治疗开始前一周、治疗后一周及治疗结束后三个月进行。
关键数值与推荐
- 主动LLLT参数:632 nm,830 mW,400 cm2,30分钟,每次总剂量3.74 J/cm2。
- 假LLLT设备功率<1 mW,仅模拟照射。
- 治疗频率:每周3次,共6周18次。
- 评估时间点:治疗前一周、治疗后一周、治疗后三个月。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Photobiomodulation using low-level laser therapy (LLLT) has been tested as a new technique to optimize recovery of patients with traumatic brain injury (TBI). The aim of this study is to evaluate inhibitory attentional control after 18 sessions of active LLLT and compare with the placebo group (sham LLLT). Our exploratory analysis will evaluate the efficacy of the active LLLT on verbal and visuospatial episodic memory, executive functions (working memory, verbal and visuospatial fluency, attentional processes), and anxiety and depressive symptoms compared to the sham group. METHODS/DESIGN: A randomized double-blinded trial will be made in 36 patients with moderate and severe TBI. The active LLLT will use an optical device composed of LEDs emitting 632 nm of radiation at the site with full potency of 830 mW. The cranial region with an area of 400 cm2 will be irradiated for 30 min, giving a total dose per session of 3.74 J/cm2. The sham LLLT group contains only an LED device with power < 1 mW, only serving to simulate the irradiation. Each patient will be irradiated three times per week for six weeks, totaling 18 sessions. Neuropsychological assessments will be held one week before the beginning of the sessions, after one week, and three months after the end of LLLT sessions. Memory domain, attention, executive functioning, and visual construction will be evaluated, in addition to symptoms of depression, anxiety, and social demographics. DISCUSSION: LLLT has been demonstrated as a safe and effective technique in significantly improving the memory, attention, and mood performance in healthy and neurologic patients. We expect that our trial can complement previous finds, as an effective low-cost therapy to improve cognitive sequel after TBI. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02393079 . Registered on 20 February 2015.
引用
- Poiani GDCR, Zaninotto AL, Carneiro AMC, et al. Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: a randomized controlled trial study protocol. Trials. 2018. PMID: 29310710. doi:10.1186/s13063-017-2414-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。